Olaplex Holdings, Inc. (NASDAQ:OLPX – Get Free Report) CFO Catherine Dunleavy sold 93,809 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $1.26, for a total value of $118,199.34. Following the completion of the transaction, the chief financial officer owned 3,026,885 shares of the company’s stock, valued at approximately $3,813,875.10. This represents a 3.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Olaplex Price Performance
Olaplex stock opened at $1.27 on Thursday. Olaplex Holdings, Inc. has a 52 week low of $0.99 and a 52 week high of $1.84. The company has a quick ratio of 4.00, a current ratio of 4.58 and a debt-to-equity ratio of 0.40. The firm’s 50-day simple moving average is $1.53 and its 200 day simple moving average is $1.35. The firm has a market capitalization of $850.14 million, a PE ratio of -127.00 and a beta of 2.24.
Olaplex (NASDAQ:OLPX – Get Free Report) last posted its earnings results on Thursday, March 5th. The company reported $0.01 earnings per share for the quarter, meeting the consensus estimate of $0.01. Olaplex had a negative net margin of 2.19% and a positive return on equity of 1.07%. The firm had revenue of $105.12 million during the quarter, compared to the consensus estimate of $104.21 million. During the same period last year, the firm posted $0.01 EPS. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. On average, equities research analysts predict that Olaplex Holdings, Inc. will post 0.1 EPS for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
OLPX has been the subject of a number of analyst reports. Morgan Stanley set a $1.40 price target on Olaplex in a report on Tuesday, March 10th. Telsey Advisory Group reaffirmed a “market perform” rating and set a $2.00 price objective on shares of Olaplex in a research note on Monday, March 2nd. Barclays set a $1.75 price objective on Olaplex in a research report on Friday, January 16th. Zacks Research raised shares of Olaplex from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 19th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Olaplex in a report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $1.88.
Get Our Latest Stock Report on Olaplex
About Olaplex
Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.
Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.
See Also
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
